
Conformis CFMS
Quarterly report 2023-Q2
added 08-02-2023
Conformis P/CF Ratio 2011-2026 | CFMS
Annual P/CF Ratio Conformis
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.252 | -0.51 | -3.44 | -11.1 | -1.04 | -1.47 | -6.03 | -4.09 | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -0.252 | -11.1 | -3.49 |
P/CF Ratio of other stocks in the Medical devices industry
| Issuer | P/CF Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Electromed
ELMD
|
15.3 | $ 25.3 | 0.8 % | $ 214 M | ||
|
Helius Medical Technologies
HSDT
|
-0.34 | $ 2.0 | 0.76 % | $ 1.22 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
-80.1 | - | - | $ 1.77 B | ||
|
IRIDEX Corporation
IRIX
|
-7.85 | $ 1.04 | 0.72 % | $ 17.6 M | ||
|
AdaptHealth Corp.
AHCO
|
2 | $ 12.96 | -0.84 % | $ 1.75 B | ||
|
Allied Healthcare Products
AHPI
|
-0.98 | - | 3.58 % | $ 2.21 M | ||
|
Lianluo Smart Limited
LLIT
|
-62.7 | - | 24.59 % | $ 44.8 M | ||
|
OrthoPediatrics Corp.
KIDS
|
-90 | $ 14.75 | 0.75 % | $ 346 M | ||
|
LivaNova PLC
LIVN
|
15 | $ 58.86 | -0.1 % | $ 3.21 B | ||
|
Apollo Endosurgery
APEN
|
-12.9 | - | - | $ 475 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
-3.31 | - | -5.86 % | $ 30.6 M | ||
|
Avinger
AVGR
|
-0.18 | - | -20.74 % | $ 369 K | ||
|
Axonics Modulation Technologies
AXNX
|
885 | - | - | $ 3.31 B | ||
|
EDAP TMS S.A.
EDAP
|
-4.42 | $ 3.35 | 1.06 % | $ 125 M | ||
|
Aziyo Biologics
AZYO
|
-1.24 | - | 1.37 % | $ 20.5 M | ||
|
BIOLASE
BIOL
|
-0.0136 | - | -13.19 % | $ 166 K | ||
|
PAVmed
PAVM
|
-1.12 | $ 8.54 | -4.32 % | $ 5.73 M | ||
|
Insulet Corporation
PODD
|
31.9 | $ 167.15 | 4.46 % | $ 11.8 B | ||
|
BioSig Technologies
BSGM
|
-1.53 | - | 37.08 % | $ 85.7 M | ||
|
ClearPoint Neuro
CLPT
|
-13.2 | $ 10.44 | 0.97 % | $ 296 M | ||
|
Sintx Technologies
SINT
|
-0.806 | $ 2.07 | 4.02 % | $ 5.74 M | ||
|
Cardiovascular Systems
CSII
|
-24.2 | - | 0.15 % | $ 844 M | ||
|
Cytosorbents Corporation
CTSO
|
-2.82 | $ 0.63 | -1.29 % | $ 39.2 M | ||
|
CryoLife, Inc.
CRY
|
180 | - | -4.14 % | $ 702 M | ||
|
Stryker Corporation
SYK
|
34.6 | $ 316.51 | 0.49 % | $ 121 B | ||
|
Tactile Systems Technology
TCMD
|
14.9 | $ 22.36 | -0.62 % | $ 511 M | ||
|
TELA Bio
TELA
|
-1.15 | $ 0.94 | 9.29 % | $ 44.1 M | ||
|
CHF Solutions, Inc.
CHFS
|
-0.0621 | - | 1.15 % | $ 34.5 M | ||
|
Tandem Diabetes Care
TNDM
|
-130 | $ 18.53 | 2.04 % | $ 1.26 B | ||
|
Soliton, Inc.
SOLY
|
-18.5 | - | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
-1.02 | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
-30.7 | - | 0.03 % | $ 1.58 B | ||
|
Dynatronics Corporation
DYNT
|
6.49 | - | 14.99 % | $ 929 K | ||
|
Eargo
EAR
|
-0.145 | - | - | $ 10.2 M | ||
|
Misonix, Inc.
MSON
|
-6.81 | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
-25 | - | - | $ 111 M | ||
|
Varex Imaging Corporation
VREX
|
12 | $ 11.38 | 3.13 % | $ 471 M | ||
|
Vivos Therapeutics
VVOS
|
-0.989 | $ 0.83 | 6.36 % | $ 8.53 M | ||
|
Butterfly Network
BFLY
|
-18.4 | $ 4.55 | -7.52 % | $ 963 M | ||
|
Second Sight Medical Products
EYES
|
-10.8 | - | -0.97 % | $ 54.4 M | ||
|
Intersect ENT, Inc.
XENT
|
-20.1 | - | - | $ 955 M | ||
|
GBS
GBS
|
-0.256 | - | -0.57 % | $ 7.12 M | ||
|
Globus Medical
GMED
|
16.6 | $ 88.88 | 1.24 % | $ 12 B | ||
|
Delcath Systems
DCTH
|
14.5 | $ 10.28 | 0.69 % | $ 368 M | ||
|
CONMED Corporation
CNMD
|
7.72 | $ 37.15 | 3.31 % | $ 1.15 B | ||
|
Inspire Medical Systems
INSP
|
15.1 | $ 53.58 | 0.32 % | $ 1.57 B | ||
|
Integer Holdings Corporation
ITGR
|
15.2 | $ 85.0 | 1.59 % | $ 2.95 B | ||
|
Edwards Lifesciences Corporation
EW
|
30.6 | $ 81.56 | 0.43 % | $ 47.7 B | ||
|
Invacare Corporation
IVC
|
-0.436 | - | - | $ 24.7 M |